Literature DB >> 8590121

Continuous cold therapy in total knee arthroplasty.

D W Leutz1, H Harris.   

Abstract

This article describes a retrospective study that assessed 52 consecutive patients who underwent total knee arthroplasty (TKA) between January 1, 1992 and September 15, 1992. Thirty-three patients underwent TKA and received cold therapy pads placed over a thin dressing in the operating room. Nineteen patients underwent TKA using an identical operative and postoperative procedure, but did not receive continuous cold therapy. Continuous cold therapy consisted of two sterile plastic pads connnected by rubber hoses containing cool water from an electric main unit that maintained a constant temperature of 42 degrees F for the immediate postoperative period. Cold therapy pads were used an average of 3 days and removed with the first dressing change. Patients who had continuous cold therapy averaged a 200 cc decrease in postoperative blood loss. There was no significant difference in the amount of narcotic use, transfusion requirements, or hospital stay between the two groups. Postoperative swelling and range of motion were not consistently recorded. Twenty-eight other variables also examined not significant. Based on these results, we cannot recommend continuous cold therapy or justify the extra expense for all patients who undergo TKA.

Entities:  

Mesh:

Year:  1995        PMID: 8590121

Source DB:  PubMed          Journal:  Am J Knee Surg        ISSN: 0899-7403


  2 in total

1.  Functional performance with a single-radius femoral design total knee arthroplasty.

Authors:  Enrique Gómez-Barrena; Carmelo Fernandez-García; Almudena Fernandez-Bravo; Raquel Cutillas-Ruiz; Gloria Bermejo-Fernandez
Journal:  Clin Orthop Relat Res       Date:  2010-05       Impact factor: 4.176

2.  Impact of a new cryotherapy device on early rehabilitation after primary total knee arthroplasty (TKA): a prospective randomised controlled trial.

Authors:  Patrick Sadoghi; Sandro Hasenhütl; Gerald Gruber; Lukas Leitner; Andreas Leithner; Gudrun Rumpold-Seitlinger; Norbert Kastner; Rudolf W Poolman; Mathias Glehr
Journal:  Int Orthop       Date:  2018-01-22       Impact factor: 3.075

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.